EMP1 and neoplasm: In vivo experiments showed that EMP1 overexpression promoted tumor growth and enhanced cisplatin resistance of tumor cells, whereas silencing EMP1 expression inhibited tumor growth and reduced tumor cell resistance to cisplatin.